What is the typical dose of Sultamicillin (Ampicillin/Sulbactam) for treating Urinary Tract Infections (UTIs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sultamicillin Dosing for Urinary Tract Infections

The recommended dose of sultamicillin for treating urinary tract infections is 375 mg three times daily or 750 mg twice daily for uncomplicated UTIs, and higher doses of 750 mg three times daily may be needed for complicated UTIs. 1, 2

Dosing Recommendations Based on UTI Type

Uncomplicated UTIs

  • For acute uncomplicated cystitis, sultamicillin 375 mg three times daily or 750 mg twice daily for 3-5 days is effective 1, 2
  • Clinical efficacy rates of 95.3% have been demonstrated with the twice-daily regimen, making it a convenient option with good patient compliance 2
  • Bacterial eradication rates of over 90% have been observed with these dosing regimens, particularly for E. coli (92.2%) 1

Complicated UTIs

  • For complicated UTIs, sultamicillin 375 mg three times daily or 750 mg twice daily for 5-7 days is recommended 1, 3
  • Higher doses up to 750 mg three times daily (2250 mg/day) may be required for severe infections or resistant organisms 1
  • Treatment duration should be 7-14 days for complicated UTIs, following general UTI treatment principles 4

Special Considerations

Pediatric Dosing

  • For children, sultamicillin can be dosed at 50 mg/kg/day divided into two daily doses 5
  • Pediatric fine granule formulations may be dosed at 187.5 mg 2-3 times daily 3

Antimicrobial Resistance Considerations

  • Sultamicillin is particularly valuable when beta-lactamase-producing organisms are suspected 5
  • Local resistance patterns should guide empiric antibiotic selection 4
  • Sultamicillin maintains efficacy against many beta-lactamase-producing organisms that would be resistant to ampicillin alone 1, 5

Comparative Efficacy

  • Sultamicillin has shown comparable efficacy to amoxicillin-clavulanate for UTIs, with the advantage of requiring only twice-daily dosing 2
  • Clinical success rates of 95.3% for sultamicillin vs. 90.3% for amoxicillin-clavulanate have been reported 2
  • Sultamicillin's twice-daily dosing may improve adherence compared to medications requiring three daily doses 2

Safety Profile

  • Sultamicillin is generally well-tolerated with minimal adverse effects 2, 6
  • Most common side effects include mild gastrointestinal disturbances such as diarrhea or loose stools 5
  • Serious adverse events are rare, with discontinuation rates due to side effects being low 5

Clinical Pearls

  • For empiric treatment, consider local resistance patterns before selecting sultamicillin 4
  • In patients with suspected pyelonephritis or complicated UTIs, obtain urine culture before starting treatment 4
  • Consider parenteral therapy initially for severe infections before transitioning to oral sultamicillin 4
  • For patients with renal impairment, dose adjustment may be necessary 6
  • Sultamicillin provides a convenient oral follow-up option after initial parenteral beta-lactam therapy 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.